Sami Corwin
Stock Analyst at William Blair
(n/a)
# 4,435
Out of 4,843 analysts
11
Total ratings
16.67%
Success rate
-47.77%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sami Corwin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RARE Ultragenyx Pharmaceutical | Initiates: Outperform | $65 | $34.03 | +91.01% | 1 | May 28, 2025 | |
| NKTX Nkarta | Downgrades: Market Perform | n/a | $1.74 | - | 1 | May 15, 2025 | |
| CRGX CARGO Therapeutics | Downgrades: Market Perform | n/a | $4.23 | - | 2 | Jan 30, 2025 | |
| APLT Applied Therapeutics | Downgrades: Market Perform | n/a | $0.35 | - | 1 | Dec 23, 2024 | |
| TNYA Tenaya Therapeutics | Initiates: Outperform | n/a | $0.46 | - | 1 | Jun 10, 2024 | |
| NGNE Neurogene | Initiates: Outperform | n/a | $17.01 | - | 1 | Mar 21, 2024 | |
| MESO Mesoblast | Downgrades: Market Perform | n/a | $10.62 | - | 1 | Aug 4, 2023 | |
| CRSP CRISPR Therapeutics AG | Reinstates: Outperform | $75 | $36.29 | +106.67% | 1 | May 30, 2023 | |
| LEGN Legend Biotech | Initiates: Market Perform | n/a | $28.95 | - | 1 | May 25, 2023 | |
| QURE uniQure | Initiates: Outperform | $66 | $14.47 | +356.12% | 1 | Oct 27, 2021 |
Ultragenyx Pharmaceutical
May 28, 2025
Initiates: Outperform
Price Target: $65
Current: $34.03
Upside: +91.01%
Nkarta
May 15, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $1.74
Upside: -
CARGO Therapeutics
Jan 30, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $4.23
Upside: -
Applied Therapeutics
Dec 23, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $0.35
Upside: -
Tenaya Therapeutics
Jun 10, 2024
Initiates: Outperform
Price Target: n/a
Current: $0.46
Upside: -
Neurogene
Mar 21, 2024
Initiates: Outperform
Price Target: n/a
Current: $17.01
Upside: -
Mesoblast
Aug 4, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $10.62
Upside: -
CRISPR Therapeutics AG
May 30, 2023
Reinstates: Outperform
Price Target: $75
Current: $36.29
Upside: +106.67%
Legend Biotech
May 25, 2023
Initiates: Market Perform
Price Target: n/a
Current: $28.95
Upside: -
uniQure
Oct 27, 2021
Initiates: Outperform
Price Target: $66
Current: $14.47
Upside: +356.12%